2024 Bloom Burton Award Winner - Roberto Bellini formerly of BELLUS Health

Roberto Bellini, the winner of the 2024 Bloom Burton Award and one of the biotech industry's premier public company CEOs shares his journey as the former President and Chief Executive Officer at BELLUS Health.

At BELLUS Health, Roberto assembled a world class management team and institutional investors as Bellus acquired and advanced Camlipixant, a potential best in class P2X3 antagonist for chronic cough. After advancing the drug into a global phase 3 program, Bellus was acquired last year by GlaxoSmithKline for US$2 billion.

The Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made the greatest contribution to Canada’s innovative healthcare industry in the previous year. Nominees are accepted from any of the biotechnology, pharmaceutical, medical device, diagnostic/imaging, research instrumentation, consumer health, services or healthcare IT sectors, and equal consideration is given to contributions across any stage of development – from discovery to commercial end markets.

The Bloom Burton Award winner is chosen by an esteemed panel of judges, all of whom are respected international leaders in healthcare investment, entrepreneurship and journalism.

Learn more about Bloom Burton & Co. at www.bloomburton.com